Promotes Significant Weight Loss / Activates Multiple Hormones for Weight Reduction
Retatrutide is a synthetic peptide currently in clinical development, classified as a triple agonist of the GLP‑1, GIP, and glucagon receptors. It was designed to simultaneously modulate multiple metabolic pathways involved in glycemic control, energy balance, and body weight regulation.
R$ 1.932,00
10 in stock
💡 Digite seu CEP para calcular automaticamente o frete e prazo de entrega
We accept USDT as our exclusive payment method, ensuring fast transactions, enhanced privacy, and efficient order processing.
Warning — For Research Use Only
Scientific content intended for research laboratories only. It is not a clinical, therapeutic, or diagnostic recommendation. Use is restricted to qualified professionals. Consult specialists before purchasing or using. Biopelabs reinforces its commitment to ethical and responsible use.
Discover Our Complete Catalog
Browse our full peptide catalog and explore additional compounds. Click any product to view its details and discover more research solutions.
Retatrutide is a long‑chain peptide structurally optimized to exhibit high affinity and functional activity at the GLP‑1 (glucagon‑like peptide‑1), GIP (glucose‑dependent insulinotropic polypeptide), and glucagon receptors. This triple mechanism promotes:
Glucose‑dependent stimulation of insulin secretion
Modulation of glucagon secretion
Increased energy expenditure
Reduced food intake
The molecule has been chemically modified to extend its plasma half‑life, incorporating non‑natural amino acid substitutions and stabilization strategies against proteolytic degradation, enabling subcutaneous administration at prolonged intervals. Retatrutide is currently in advanced clinical studies, primarily targeting obesity and metabolic disorders.
The peptides undergo a lyophilization process, a technique that contributes to greater stability and durability, while preserving purity and molecular structure during storage. It is important to note that no bulking agents are used during this procedure.
Intended Use
Biopelabs advises: this material is provided exclusively as a chemical input for research purposes. Its use is restricted to in vitro assays and experimental activities in laboratory settings. The information presented is strictly for informational and educational purposes. Handling must be carried out only by properly qualified professionals. This product is not classified as a medication, food, or cosmetic, and must not be used, marketed, or described as such.
Research
Scientific Research on the Retatrutide Peptide
Retatrutide is a next-generation peptide that has attracted significant interest in pharmaceutical research due to its multi-target action in energy metabolism. Preclinical studies indicate that this compound has relevant investigational potential in areas such as obesity, type 2 diabetes, and complex metabolic disorders. Although clinical data in humans are still under development, early results from experimental models position Retatrutide as an important subject of study in modern pharmacology.
Multi-Receptor Mechanism of Action
The primary distinguishing feature of Retatrutide lies in its ability to simultaneously activate three key hormonal receptors involved in metabolic regulation:
GLP-1, GIP, and glucagon.
This integrated activation has been widely studied for enabling a more comprehensive physiological response, acting across different metabolic pathways. Experimental research investigates how this approach may:
Influence appetite control and satiety by modulating central and peripheral signals related to food intake
• Increase energy expenditure through activation of glucagon-associated metabolic pathways
• Improve glycemic control by impacting both insulin secretion and insulin sensitivity
This combination of effects makes Retatrutide a strategic compound for research focused on multifactorial metabolic conditions, such as metabolic syndrome.
Retatrutide in Research on Body Weight and Glucose Metabolism
Preclinical studies have explored the potential of Retatrutide in preventing diet-induced weight gain and reducing insulin resistance. Data suggest that its integrated mechanism of action may result in more consistent metabolic effects compared to single-target agonists.
In the context of type 2 diabetes research, Retatrutide is being investigated for its ability to modulate glucose homeostasis, influencing both hepatic glucose production and peripheral glucose uptake.
These combined effects make the peptide a promising target in studies focused on energy balance and systemic metabolism.
Importance of Peptide Quality in Scientific Studies
The reliability of results in pharmaceutical research is directly dependent on the quality and consistency of the compounds used. Biopelabs provides Retatrutide exclusively for research purposes, with strict control over synthesis, purification, and analysis.
The use of peptides with a high degree of analytical purity contributes to:
Greater experimental reproducibility
• Reduced interference associated with impurities
• Increased reliability in comparative and longitudinal studies
These factors are essential for the safe and consistent advancement of scientific research.
Retatrutide and the Advancement of Peptide-Based Therapies
Retatrutide represents a growing trend in pharmacology: the development of molecules capable of acting simultaneously on multiple physiological pathways. This approach reflects a paradigm shift in the research of metabolic treatments, aiming for more integrated and effective solutions.
Access to high-quality peptides, such as those provided by Biopelabs, is a key element in enabling studies that investigate the true potential of these new therapeutic strategies.
Final Considerations
Scientific research involving Retatrutide (CAS 2381089-83-2) plays a relevant role in the current landscape of pharmaceutical investigation. Its multi-receptor mechanism and widely studied metabolic effects make it a compound of significant experimental interest.
Biopelabs remains committed to supporting scientific research by supplying peptides intended exclusively for experimental studies, contributing to the advancement of knowledge and the development of next-generation therapies.
Disclaimer: The products offered by BiopeLabs are intended for research and laboratory use only. They are not approved for human consumption, therapeutic, diagnostic, or veterinary use. By purchasing from our website, you acknowledge that you are a qualified researcher or purchasing on behalf of a legitimate research institution and agree to use these products in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.